Photobiomodulation shows promise as safe and tolerable adjunct therapy for Parkinson’s Disease, recent trial suggests Post author: Post published:December 5, 2023 Post category:uncategorized A safe and feasible treatment option for reducing the motor signs of Parkinson’s disease. You Might Also Like Nanowire-based technology detects cancer-associated miRNAs in urine November 16, 2024 New triplet therapies show promise for relapsed and newly diagnosed leukemias December 9, 2024 Tea consumption increases bone density and reduces the risk of osteoporosis February 27, 2024